Health Technology · Biotechnology · NSE: FERMENTA · data 2026-10-09
Fermenta Biotech Ltd
Health check: Strong (7.6/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹517.55
Market cap
₹1,583 cr
P/E
25
P/B
—
ROE
18.7%
ROCE
20.8%
Debt / equity
0.28
Dividend yield
0.70%
1-year return
66.9%
52-week high
₹582.65
52-week low
₹248.85
Operating margin
13.4%
Growth
| Revenue (last 12 months) | ₹511 cr |
| Net profit (last 12 months) | ₹60 cr |
| Sales growth, 3 years (yearly) | 14.5% |
| Profit growth, 3 years (yearly) | — |
Similar companies
Anthem Biosciences Limited (ANTHEM) · Rubicon Research Limited (RUBICON) · Akums Drugs and Pharmaceuticals Limited (AKUMS) · Fabtech Technologies Limited (FABTECH) · Haleos Labs Ltd. (HALEOSLABS)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open FERMENTA in NSE Scanner →